Literature DB >> 6748150

Respiratory movement of the pancreas: an ultrasonic study.

P J Bryan, S Custar, J R Haaga, V Balsara.   

Abstract

Respiratory movement of the pancreas was documented ultrasonically in 36 normal patients and volunteers. Pancreatic excursion from full inspiration to full expiration was measured in the plane of the superior mesenteric artery in supine, prone, and decubitus positions. Excursions ranged from 0 to 3.5 cm. The average respiratory excursion was 1.8 cm in the supine position, 1.9 cm when prone, and 2.2 cm in the lateral decubitus position. Such respiratory movement of the pancreas has obvious implications both for static B-mode ultrasound scanning and for CT scanning.

Entities:  

Mesh:

Year:  1984        PMID: 6748150     DOI: 10.7863/jum.1984.3.7.317

Source DB:  PubMed          Journal:  J Ultrasound Med        ISSN: 0278-4297            Impact factor:   2.153


  13 in total

1.  A preliminary probe into the movement of pancreatic lesions and factors that influence it.

Authors:  Y-C Song; J-Q You; Z-Y Yuan; W Wang; X-Y Li; P Wang
Journal:  Br J Radiol       Date:  2010-06       Impact factor: 3.039

2.  Four-dimensional intensity-modulated radiation therapy planning for dynamic tracking using a direct aperture deformation (DAD) method.

Authors:  Minzhi Gui; Yuanming Feng; Byongyong Yi; Anil Arvind Dhople; Cedric Yu
Journal:  Med Phys       Date:  2010-05       Impact factor: 4.071

3.  High-quality t2-weighted 4-dimensional magnetic resonance imaging for radiation therapy applications.

Authors:  Dongsu Du; Shelton D Caruthers; Carri Glide-Hurst; Daniel A Low; H Harold Li; Sasa Mutic; Yanle Hu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-03-30       Impact factor: 7.038

4.  Image-guided intensity-modulated radiotherapy for pancreatic carcinoma.

Authors:  Martin Fuss; Adrian Wong; Clifton D Fuller; Bill J Salter; Cristina Fuss; Charles R Thomas
Journal:  Gastrointest Cancer Res       Date:  2007-01

5.  3D dosimetric validation of ultrasound-guided radiotherapy with a dynamically deformable abdominal phantom.

Authors:  Charles K Matrosic; Wesley Culberson; Andrew Shepard; Sydney Jupitz; Bryan Bednarz
Journal:  Phys Med       Date:  2021-04-23       Impact factor: 2.685

6.  Geometric Reproducibility of Fiducial Markers and Efficacy of a Patient-Specific Margin Design Using Deep Inspiration Breath Hold for Stereotactic Body Radiation Therapy for Pancreatic Cancer.

Authors:  Sarah Han-Oh; Colin Hill; Ken Kang-Hsin Wang; Kai Ding; Jean L Wright; Sara Alcorn; Jeffrey Meyer; Joseph Herman; Amol Narang
Journal:  Adv Radiat Oncol       Date:  2021-01-22

7.  Dosimetric and motion analysis of margin-intensive therapy by stereotactic ablative radiotherapy for resectable pancreatic cancer.

Authors:  John H Heinzerling; Ross Bland; John C Mansour; Roderich E Schwarz; Ezequiel Ramirez; Chuxiong Ding; Ramzi Abdulrahman; Thomas P Boike; Timothy Solberg; Robert D Timmerman; Jeffrey J Meyer
Journal:  Radiat Oncol       Date:  2011-10-28       Impact factor: 3.481

8.  Determination of acquisition frequency for intrafractional motion of pancreas in CyberKnife radiotherapy.

Authors:  Huailing Zhang; Guoru Zhao; David Djajaputra; Yaoqin Xie
Journal:  ScientificWorldJournal       Date:  2014-05-13

Review 9.  The road to clinical use of high-intensity focused ultrasound for liver cancer: technical and clinical consensus.

Authors:  Jean-Francois Aubry; Kim Butts Pauly; Chrit Moonen; Gail Ter Haar; Mario Ries; Rares Salomir; Sham Sokka; Kevin Michael Sekins; Yerucham Shapira; Fangwei Ye; Heather Huff-Simonin; Matt Eames; Arik Hananel; Neal Kassell; Alessandro Napoli; Joo Ha Hwang; Feng Wu; Lian Zhang; Andreas Melzer; Young-Sun Kim; Wladyslaw M Gedroyc
Journal:  J Ther Ultrasound       Date:  2013-08-01

10.  Minimal Inter-Fractional Fiducial Migration during Image-Guided Lung Stereotactic Body Radiotherapy Using SuperLock Nitinol Coil Fiducial Markers.

Authors:  Yi Rong; Jose G Bazan; Ashley Sekhon; Karl Haglund; Meng Xu-Welliver; Terence Williams
Journal:  PLoS One       Date:  2015-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.